Clinical Trial: Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Solid Tumor, Adult
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Multicenter, Multi-arm Phase 1 Study Evaluating the Safety and Pharmacokinetics of ADU-1805 in Adults With Advanced Solid Tumors
Brief Summary:
This first-in-human, open-label, multicenter, multi-arm dose-escalation study is designed to evaluate the safety, PK, and PD of ADU-1805, an anti- SIRP? monoclonal antibody, as monotherapy and in combination with pembrolizumab (anti-PD-1 antibody).
Read more